Biblio Discovery — Demo Discovery Service

12 results for "Shibi Likhite"

Showing 1–12 · 0.66 seconds · RSS

  1. Journal Article Full text

    A Novel Retinal Gene Therapy Strategy for Batten Disease and Beyond

    Maura Schwartz; Alex Campbell; Joseph Caporale et al.

    Proceedings, Vol. 71 No. 1 · 2020 · English · DOAJ

    Batten Disease is a fatal lysosomal storage disorder characterized by cognitive and [...]

  2. Journal Article

    Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8 mnd mice

    Andrew D. Holmes; Katherine A. White; Melissa A. Pratt et al.

    Orphanet Journal of Rare Diseases, Vol. 17 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background CLN8-Batten disease (CLN8 disease) is a rare neurodegenerative disorder characterized phenotypically by progressive deterioration of motor and cognitive abilities, visual symptoms, epileptic seizures, and premature death. Mutations in CLN8 results in characteristic Batten…

  3. Journal Article

    AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models

    Yoshiko Murakami; Saori Umeshita; Kae Imanishi et al.

    Molecular Therapy: Methods & Clinical Development, Vol. 32 No. 1 · 2024 · English · DOAJ

    Thirty genes are involved in the biosynthesis and modification of glycosylphosphatidylinositol (GPI)-anchored proteins, and defects in these genes cause inherited GPI deficiency (IGD). PIGA is X-linked and involved in the first step of GPI biosynthesis, and only males are affected by variations in…

  4. Journal Article Full text

    In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders

    Julieth Andrea Sierra-Delgado; Shrestha Sinha-Ray; Abuzar Kaleem et al.

    Biology, Vol. 12 No. 6 · 2023 · English · DOAJ Scopus

    Spinal Muscular Atrophy (SMA) is the leading genetic cause of infant mortality. The most common form of SMA is caused by mutations in the SMN1 gene, located on 5q (SMA). On the other hand, mutations in IGHMBP2 lead to a large disease spectrum with no clear genotype–phenotype correlation, which…

  5. Journal Article

    The postnatal injection of AAV9-FOXG1 rescues corpus callosum agenesis and other brain deficits in the mouse model of FOXG1 syndrome

    Shin Jeon; Jaein Park; Shibi Likhite et al.

    Molecular Therapy: Methods & Clinical Development, Vol. 32 No. 3 · 2024 · English · DOAJ

    Heterozygous mutations in the FOXG1 gene manifest as FOXG1 syndrome, a severe neurodevelopmental disorder characterized by structural brain anomalies, including agenesis of the corpus callosum, hippocampal reduction, and myelination delays. Despite the well-defined genetic basis of FOXG1 syndrome…

  6. Journal Article

    In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans

    Maura K. Schwartz; Shibi Likhite; Tatyana A. Vetter et al.

    Molecular Therapy: Methods & Clinical Development, Vol. 30 · 2023 · English · DOAJ

    Anc80L65 is a synthetic, ancestral adeno-associated virus that has high tropism toward retinal photoreceptors after subretinal injection in mice and non-human primates. We characterized, for the first time, the post-intravitreal cell-specific transduction profile of Anc80L65 compared with AAV9…

  7. Journal Article Full text

    Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes

    Cátia Gomes; Catarina Sequeira; Shibi Likhite et al.

    Cells, Vol. 11 No. 7 · 2022 · English · DOAJ Scopus

    A lack of stratification methods in patients with amyotrophic lateral sclerosis (ALS) is likely implicated in therapeutic failures. Regional diversities and pathophysiological abnormalities in astrocytes from mice with SOD1 mutations (mSOD1-ALS) can now be explored in human patients using somatic…

  8. Journal Article

    AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model

    Elisa Pagliari; Alessia Anastasia; Floriana Bellandi et al.

    Journal of Biomedical Science, Vol. 33 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Mutations in the Immunoglobulin Mu DNA Binding Protein 2 (IGHMBP2) gene cause Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1), a rare, infantile, and fatal motor neuron disease, as well as the milder Charcot-Marie-Tooth disease type 2S (CMT2S). Gene therapy has…

  9. Journal Article

    Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS

    Tommaso Iannitti; Joseph M. Scarrott; Shibi Likhite et al.

    Molecular Therapy: Nucleic Acids, Vol. 12 · 2018 · English · DOAJ Scopus

    Of familial amyotrophic lateral sclerosis (fALS) cases, 20% are caused by mutations in the gene encoding human cytosolic Cu/Zn superoxide dismutase (hSOD1). Efficient translation of the therapeutic potential of RNAi for the treatment of SOD1-ALS patients requires the development of vectors that are…

  10. Journal Article

    Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice

    Katherine A. White; Hemanth R. Nelvagal; Timothy A. Poole et al.

    Molecular Therapy: Methods & Clinical Development, Vol. 20 · 2021 · English · DOAJ

    Batten disease is a family of rare, fatal, neuropediatric diseases presenting with memory/learning decline, blindness, and loss of motor function. Recently, we reported the use of an AAV9-mediated gene therapy that prevents disease progression in a mouse model of CLN6-Batten disease (Cln6nclf)…

  11. Journal Article

    Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease

    Tyler B. Johnson; Jon J. Brudvig; Shibi Likhite et al.

    Frontiers in Genetics, Vol. 14 · 2023 · English · DOAJ Scopus

    CLN3 disease, caused by biallelic mutations in the CLN3 gene, is a rare pediatric neurodegenerative disease that has no cure or disease modifying treatment. The development of effective treatments has been hindered by a lack of etiological knowledge, but gene replacement has emerged as a promising…

  12. Journal Article

    Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype

    Song Lou; Rachisan DJiake Tihagam; Urszula N. Wasko et al.

    Nature Communications, Vol. 16 No. 1 · 2025 · English · DOAJ Scopus

    Abstract X chromosome inactivation (XCI) is induced by Xist long non-coding RNA and protein-coding genes. However, the role of small non-coding RNA function in XCI remains unidentified. Our genome-wide, loss-of-function CRISPR/Cas9 screen in female fibroblasts identified microRNAs (miRNAs) as…